NeoGenomics Investor Relations Material
Latest events
Q2 2025
NeoGenomics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from NeoGenomics Inc
Access all reports
NeoGenomics Inc provides cancer-focused genetic testing services, including clinical and research laboratory diagnostics. The company offers molecular, cytogenetic, and flow cytometry testing to pathologists, oncologists, and pharmaceutical companies. It supports precision medicine and oncology drug development. The company is headquartered in Fort Myers, Florida, and its shares are listed on the NASDAQ.
Key slides for NeoGenomics Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
NeoGenomics Inc
Q2 2025
NeoGenomics Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
NEO
Country
🇺🇸 United States